{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T07:08:28Z","timestamp":1767164908986,"version":"build-2238731810"},"reference-count":32,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["mSphere"],"published-print":{"date-parts":[[2018,4,25]]},"abstract":"<jats:p>The re-creation of horsepox virus, an extinct orthopoxvirus with similarity to smallpox virus, has caused concerns in the biosecurity and biodefense communities that the technical capabilities achieved could advance the re-creation of smallpox virus by nefarious actors. The work is now published.<\/jats:p>","DOI":"10.1128\/msphere.00074-18","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T05:11:45Z","timestamp":1520313105000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox Virus"],"prefix":"10.1128","volume":"3","author":[{"given":"Diane","family":"DiEuliis","sequence":"first","affiliation":[{"name":"Center for the Study of Weapons of Mass Destruction, National Defense University, U.S. Department of Defense, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2514-146X","authenticated-orcid":false,"given":"Gigi Kwik","family":"Gronvall","sequence":"additional","affiliation":[{"name":"Johns Hopkins Center for Health Security, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0188453"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1089\/hs.2017.0081"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.17226\/10827"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118283"},{"key":"e_1_3_3_6_2","unstructured":"Gaffey C. 2017. What is monkeypox? New cases of smallpox-like disease afflict Nigeria. Newsweek New York NY. http:\/\/www.newsweek.com\/monkeypox-nigeria-smallpox-symptoms-678505."},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.17226\/24832"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1190719"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.13.7281-7290.2003"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00945-06"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00319-17"},{"key":"e_1_3_3_12_2","volume-title":"DNA synthesis and biosecurity: lessons learned and options for the future","author":"Carter SR","year":"2015","unstructured":"Carter SR, Friedman RM. 2015. DNA synthesis and biosecurity: lessons learned and options for the future. J. Craig Venter Institute, Rockville, MD. http:\/\/www.jcvi.org\/cms\/research\/projects\/dna-synthesis-and-biosecurity-lessons-learned-and-options-for-the-future\/overview\/."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2299"},{"key":"e_1_3_3_14_2","first-page":"62820","article-title":"Screening framework guidance for providers of synthetic double-stranded DNA","volume":"75","author":"US Department of Health and Human Services","year":"2010","unstructured":"US Department of Health and Human Services. 2010. Screening framework guidance for providers of synthetic double-stranded DNA. Fed Regist 75:62820\u201362832. http:\/\/www.gpo.gov\/fdsys\/pkg\/FR-2010-10-13\/html\/2010-25728.htm.","journal-title":"Fed Regist"},{"key":"e_1_3_3_15_2","volume-title":"Public Health Emergency Medical Countermeasures Enterprise","author":"US Department of Health and Human Services","year":"2017","unstructured":"US Department of Health and Human Services. 2017. Public Health Emergency Medical Countermeasures Enterprise. US Department of Health and Human Services, Washington, DC. https:\/\/www.phe.gov\/Preparedness\/mcm\/phemce\/Pages\/default.aspx."},{"key":"e_1_3_3_16_2","volume-title":"H.R.34\u201421st Century Cures Act","author":"114th Congress","year":"2015","unstructured":"114th Congress. 2015\u20132016. H.R.34\u201421st Century Cures Act. US Congress, Washington, DC. https:\/\/www.congress.gov\/bill\/114th-congress\/house-bill\/34"},{"key":"e_1_3_3_17_2","volume-title":"Public Health and Medical Countermeasures Enterprise Strategy and implementation Planning","author":"US Department of Health and Human Services","year":"2014","unstructured":"US Department of Health and Human Services. 2014. Public Health and Medical Countermeasures Enterprise Strategy and implementation Planning. US Department of Health and Human Services, Washington, DC. www.phe.gov\/Preparedness\/mcm\/phemce\/Documents\/2014-phemce-sip.pdf."},{"key":"e_1_3_3_18_2","author":"White House, Office of the Press Secretary","year":"2014","unstructured":"White House, Office of the Press Secretary. 18 September 2014. Executive order\u2014combating antibiotic-resistant bacteria. https:\/\/obamawhitehouse.archives.gov\/the-press-office\/2014\/09\/18\/executive-order-combating-antibiotic-resistant-bacteria.","journal-title":"Executive order\u2014combating antibiotic-resistant bacteria"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.2174\/1574884712666170809124728"},{"key":"e_1_3_3_20_2","volume-title":"Public Health and Medical Countermeasures Enterprise strategy and implementation planning","author":"US Department of Health and Human Services","year":"2016","unstructured":"US Department of Health and Human Services. 2016. Public Health and Medical Countermeasures Enterprise strategy and implementation planning. US Department of Health and Human Services, Washington, DC. www.phe.gov\/Preparedness\/mcm\/phemce\/Documents\/2016-phemce-sip.pdf."},{"key":"e_1_3_3_21_2","volume-title":"Public Health and Medical Countermeasures Enterprise strategy and implementation planning, 2017\u20132018","author":"US Department of Health and Human Services","year":"2017","unstructured":"US Department of Health and Human Services. 2017. Public Health and Medical Countermeasures Enterprise strategy and implementation planning, 2017\u20132018. US Department of Health and Human Services, Washington, DC. https:\/\/www.phe.gov\/Preparedness\/mcm\/phemce\/Documents\/2017-phemce-sip.pdf."},{"key":"e_1_3_3_22_2","volume-title":"Cangene announces extension of biodefense contract for U.S. National Stockpile","author":"Global Biodefense","year":"2013","unstructured":"Global Biodefense. 4 September 2013. Cangene announces extension of biodefense contract for U.S. National Stockpile. Global Biodefense, Seattle, WA. https:\/\/globalbiodefense.com\/2013\/09\/04\/cangene-announces-extension-of-biodefense-contract-for-u-s-national-stockpile\/."},{"key":"e_1_3_3_23_2","volume-title":"Press statement on the NSABB review of H5N1 research","author":"National Institutes of Health","year":"2011","unstructured":"National Institutes of Health. 2011. Press statement on the NSABB review of H5N1 research. National Institutes of Health, Bethesda, MD. https:\/\/www.nih.gov\/news-events\/news-releases\/press-statement-nsabb-review-h5n1-research."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00875-14"},{"key":"e_1_3_3_25_2","volume-title":"United States Government policy for oversight of life sciences DURC","author":"US Department of Health and Human Services","year":"2012","unstructured":"US Department of Health and Human Services. 2012. United States Government policy for oversight of life sciences DURC. US Department of Health and Human Services, Washington, DC. https:\/\/www.phe.gov\/s3\/dualuse\/Documents\/us-policy-durc-032812.pdf."},{"key":"e_1_3_3_26_2","volume-title":"United States Government policy for institutional oversight of life sciences DURC","author":"US Department of Health and Human Services","year":"2014","unstructured":"US Department of Health and Human Services. 2014. United States Government policy for institutional oversight of life sciences DURC. US Department of Health and Human Services, Washington, DC. https:\/\/www.phe.gov\/s3\/dualuse\/Documents\/durc-policy.pdf."},{"key":"e_1_3_3_27_2","volume-title":"Framework for guiding funding decisions about proposed research involving enhanced potential pandemic pathogens","author":"US Department of Health and Human Services","year":"2018","unstructured":"US Department of Health and Human Services. 2018. Framework for guiding funding decisions about proposed research involving enhanced potential pandemic pathogens. https:\/\/www.phe.gov\/s3\/dualuse\/Documents\/p3co.pdf."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.17226\/253"},{"key":"e_1_3_3_29_2","volume-title":"NSDD 189. National policy on transfer of scientific, technical and engineering information","author":"National Archives","year":"1985","unstructured":"National Archives. 1985. NSDD 189. National policy on transfer of scientific, technical and engineering information. National Archives, Washington, DC. https:\/\/catalog.archives.gov\/id\/6879779."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/bsp.2005.3.295"},{"key":"e_1_3_3_31_2","volume-title":"Chapter F. Tools for the identification, assessment, management, and responsible communication of dual use research of concern","author":"US Department of Health and Human Services","year":"2014","unstructured":"US Department of Health and Human Services. 2014. Guidance for responsible communication of DURC findings. In Chapter F. Tools for the identification, assessment, management, and responsible communication of dual use research of concern. US Department of Health and Human Services, Washington, DC. https:\/\/www.phe.gov\/s3\/dualuse\/Documents\/durc-companion-guide.pdf."},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","unstructured":"National Academies of Sciences Engineering and Medicine. 2017. Dual use research of concern in the life sciences: current issues and controversies. The National Academies Press Washington DC. doi:10.17226\/24761.","DOI":"10.17226\/24761"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.17226\/18255"}],"updated-by":[{"DOI":"10.1128\/msphere.00160-18","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000}}],"container-title":["mSphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mSphere.00074-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/mSphere.00074-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T23:07:43Z","timestamp":1646694463000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/mSphere.00074-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,25]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4,25]]}},"alternative-id":["10.1128\/mSphere.00074-18"],"URL":"https:\/\/doi.org\/10.1128\/msphere.00074-18","relation":{},"ISSN":["2379-5042"],"issn-type":[{"value":"2379-5042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,25]]},"assertion":[{"value":"2018-03-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00074-18"}}